CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,233,162 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04903496
NCT04903496N/ACompleted

Characteristics, Treatment, and Economic Burden of Disease of Chinese Diabetic/Non-diabetic Patients With/Without Established Cardiovascular Disease, Chronic Kidney Disease, or at High Cardiovascular Risk

Boehringer Ingelheim·observational·Posted May 26, 2021·Updated Nov 12, 2024

In Brief

An observational study for Diabetes. Completed, enrolled 1,233,162 participants across 1 site.

Detailed Summary

The study aims to investigate the clinical characteristics, treatment, and economic burden of disease of Chinese diabetic/non-diabetic patients with/without established cardiovascular disease (CVD), chronic kidney disease (CKD), or at high cardiovascular risk, including: * Primary objectives: describe the proportion of Chinese diabetic/non-diabetic patients with established cardiovascular disease, CKD, or at high cardiovascular risk including hypertension and hyperlipidemia * Secondary objectives: describe the demographic characteristics of the last visit for all patients, and the demographic characteristics of inpatients over time; investigate the clinical characteristic for all patients

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesChina

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 26, 2021
Enrollment StartSep 6, 2021
Primary CompletionJun 24, 2022
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.1 years ago